221 related articles for article (PubMed ID: 29997523)
1. Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.
Huang B; Yang J; Cheng Q; Xu P; Wang J; Zhang Z; Fan W; Wang P; Yu M
Front Physiol; 2018; 9():776. PubMed ID: 29997523
[No Abstract] [Full Text] [Related]
2. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J
Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression.
Binabaj MM; Soleimani A; Rahmani F; Avan A; Khazaei M; Fiuji H; Soleimanpour S; Ryzhikov M; Ferns GA; Bahrami A; Hassanian SM
Gene; 2019 Jul; 706():131-139. PubMed ID: 31055021
[TBL] [Abstract][Full Text] [Related]
4. High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.
Nie D; Zhang L; Guo Q; Mao X
Oncotarget; 2018 Jan; 9(1):1237-1247. PubMed ID: 29416690
[TBL] [Abstract][Full Text] [Related]
5. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
Guraya S
Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis.
Zhu J; Wang H; Xu S; Hao Y
Oncotarget; 2017 Nov; 8(59):100478-100489. PubMed ID: 29245994
[TBL] [Abstract][Full Text] [Related]
8. Predicting STAT1 as a prognostic marker in patients with solid cancer.
Zhang J; Wang F; Liu F; Xu G
Ther Adv Med Oncol; 2020; 12():1758835920917558. PubMed ID: 32426049
[TBL] [Abstract][Full Text] [Related]
9. PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets.
He S; Du W; Li M; Yan M; Zheng F
BMC Cancer; 2020 Jul; 20(1):620. PubMed ID: 32615943
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of MicroRNA-15a in Human Cancers: A Meta-Analysis and Bioinformatics.
Yang FR; Li HJ; Li TT; Zhao YF; Liu ZK; Li XR
Biomed Res Int; 2019; 2019():2063823. PubMed ID: 31061821
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
Zhang F; Chen X; Xi K; Qiu Z; Wang Y; Gui Y; Hou Y; Chen K; Zhang X
Onco Targets Ther; 2018; 11():7827-7840. PubMed ID: 30464530
[TBL] [Abstract][Full Text] [Related]
12. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis.
Thi-Hai Pham Y; Utuama O; Thomas CE; Park JA; La Vecchia C; Risch HA; Tran CT; Le TV; Boffetta P; Raskin L; Luu HN
Eur J Cancer Prev; 2020 Nov; 29(6):565-581. PubMed ID: 32898013
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis.
Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z
J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340
[No Abstract] [Full Text] [Related]
14. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
15. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
17. FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta-Analysis and Bioinformatics Analysis.
Zhang G; Wang Y; Han X; Lu T; Fu L; Jin H; Yang K; Cai H
Front Oncol; 2022; 12():799265. PubMed ID: 35719909
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
19. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
Wang L
J Ovarian Res; 2019 Apr; 12(1):37. PubMed ID: 31039792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]